18.11.2013 • News

Evonik Expanding Capacity for Isophorone in China

German chemical group Evonik is spending more than €100m capacity upgrade for isophorone and isophorone diamine at its Shanghai, China, complex. The expansion, designed to meet increasing demand from key customers in Asia, is due to be completed in Q1 2014. While the group declined to give current or future production volumes, it said total output will be "significantly" higher.

"As a world leader in isophorone-based products, we will continue to further consolidate and expand our position in this chemistry," said Ulrich Küsthardt, president of the Coatings & Additives business unit. The aim, of the investment, he said, "is to supply our Asian customers with the same high-quality products they are used to from our plants in Europe and the U.S,"

Evonik also manufactures isophorone products at Herne and Marl, German, Mobile, Alabama, U.S., and Antwerp, Belgium. 

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.